埃斯特雷马杜拉一家老年护理中心使用个性化自动配药系统与手工配药的成本分析。

Analysis of Costs Associated with the Use of Personalized Automated Dosing Systems versus Manual Preparation in a Residential Center for the Elderly in Extremadura.

作者信息

Lozano-Estevan Mᵃ Del Carmen, González-Rodríguez Liliana Guadalupe, Lozano-Fernández Rafael, Velázquez-Saornil Jorge, Sánchez-Manzano José Luis, Herrera-Peco Iván, Guerra-Guirao José Antonio, Leal-Carbajo Pilar

机构信息

VALORNUT Research Group, Department of Nutrition and Food Science, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.

Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.

出版信息

Healthcare (Basel). 2023 Feb 19;11(4):620. doi: 10.3390/healthcare11040620.

DOI:10.3390/healthcare11040620

PMID:36833154

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9957253/

Abstract

INTRODUCTION

During the SARS-CoV-2 pandemic, there has been a decrease in the supervision of the medication of subjects with chronic diseases. Customized automated dosing systems (SPDA) are devices that allow medication to be dispensed and administered, which have proven to be safe and effective for the patient and cost-effective for the healthcare system.

METHODS

an intervention study was carried out on patients from January to December 2019 in a residential centre for the elderly with more than 100 beds. The economic costs derived from manual dosing were compared with those of an automated preparation (Robotik Technology).

RESULTS

Of the 198 patients included, 195 (97.47%) of them were polymedicated. Of the total of 276 active substances of registered medicinal products, it was possible to include them in the process of automating the preparation of the SPDA 105 active pharmaceutical ingredients. A cost reduction of EUR 5062.39 per year was found using SPDA. Taking into account the active ingredients of emblistable and non-emblistable medicines, the use of SPDA resulted in savings of EUR 6120.40 per year. The system contributed to the detection of cases of therapeutic duplication and reduced the time to prepare the medication.

CONCLUSIONS

the use of SPDA is a useful and economically profitable strategy for its use in residential centres for the elderly.

摘要

引言

在新型冠状病毒肺炎大流行期间，对慢性病患者用药的监管有所减少。定制自动给药系统（SPDA）是一种可用于分发和给药的设备，已被证明对患者安全有效，对医疗保健系统具有成本效益。

方法

2019年1月至12月，在一家拥有100多张床位的老年居民中心对患者进行了一项干预研究。将手动给药产生的经济成本与自动配制（Robotik Technology）的成本进行了比较。

结果

在纳入的198例患者中，195例（97.47%）使用了多种药物。在注册药品的276种活性物质中，有105种活性药物成分可纳入SPDA自动配制过程。使用SPDA后，每年成本降低5062.39欧元。考虑到可列入清单和不可列入清单药物的活性成分，使用SPDA每年节省6120.40欧元。该系统有助于发现治疗重复的病例，并减少了准备药物的时间。